470. Clinical Effectiveness of The Monoclonal Antibody Combination Tixagevimab-Cilgavimab (T/C) as Pre-Exposure Prophylaxis (PReP) of COVID-19 among Patients (pts) with Moderate to... von Haidar, Ghady, Ludwig, Justin, Yealy, Donald M, Camacho, Haley, Chinakarn, Tina, Kip, Kevin, Koscumb, Stephen, Marroquin, Oscar, Minnier, Tami, Snyder, Graham M, Woodworth, Chelsea, Ferreira, Cátia, Glasser, Lisa, Heil, Kathleen, Lee, Andrew, Talarico, Carla, Venkatesan, Sudhir, Taylor, Sylvia, McCreary, Erin K, Mellors, John W

Volltext

471. In-Depth Characterization of SARS-CoV-2 Variants Causing Breakthrough COVID-19 Among Hospitalized Immunocompromised (IC) Patients with or without Prior Exposure to Tixagevimab... von Haidar, Ghady, Jacobs, Jana L, Salese, Erin, Ludwig, Justin, Heaps, Amy, Parikh, Urvi, Sethi, Rahil, Caruso, Lori, Camacho, Haley, Chinakarn, Tina, Edick, Stacey, Fischer, Dawn, Kramer, Kailey Hughes, Lukanski, Amy, Marks, Kiersten, Saenz-Morales, Naomi, Sierra, Sara, Ferreira, Cátia, Glasser, Lisa, Heil, Kathleen, Talarico, Carla, Taylor, Sylvia, McCreary, Erin K, Mellors, John W

Volltext